ÉèΪÊ×Ò³ ¼ÓÈëÊÕ²Ø

TOP

CATALIN FOR OPHTHALMIC 0.005% 10¡Á15mg(Pirenoxine ßÁŵ¿ËÐÁµÎÑÛÒº)
Ò©µê¹ú±ð£º  
²úµØ¹ú¼Ò£º ÈÕ±¾ 
´¦ ·½ Ò©£º ÊÇ 
ËùÊôÀà±ð£º 15ºÁÉý/Æ¿ 10Æ¿/ºÐ 
°ü×°¹æ¸ñ£º 15ºÁÉý/Æ¿ 10Æ¿/ºÐ 
¼Æ¼Ûµ¥Î»£º ºÐ 
Éú²ú³§¼ÒÖÐÎIJο¼ÒëÃû:
ǧÊÙÑuËa
Éú²ú³§¼ÒÓ¢ÎÄÃû:
Senju Pharmaceutical Co
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·1:
http://www.info.pmda.go.jp/go/pack/1319706Q2039_1_04/
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·2:
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·3:
Ô­²úµØÓ¢ÎÄÉÌÆ·Ãû:
CATALIN FOR OPHTHALMIC 0.005%(¥«¥¿¥ê¥óµãÑÛÓÃ0.005£¥)15mL/vial 10vial/box
Ô­²úµØÓ¢ÎÄÒ©Æ·Ãû:
Pirenoxine
ÖÐÎIJο¼ÉÌÆ·ÒëÃû:
CATALINÑۿƵÎÑÛÒº(¥«¥¿¥ê¥óµãÑÛÓÃ0.005£¥)15ºÁÉý/Æ¿ 10Æ¿/ºÐ
ÖÐÎIJο¼Ò©Æ·ÒëÃû:
ßÁŵ¿ËÐÁ
ÔøÓÃÃû:
¼ò½é£º

 

²¿·ÝÖÐÎÄßÁŵ¿ËÐÁ´¦·½´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£©
Ó¢ÎÄÃû£ºPirenoxine
ÉÌÆ·Ãû£ºCATALIN-K
ÖÐÎÄÃû£ºßÁŵ¿ËÐÁµÎÑÛÒº
Éú²úÉÌ£ºÇ§ÊÙÑuËa
¥«¥¿¥ê¥óµãÑÛÓÃ0.005£¥
ËaЧ·ÖÀàÃû
ÀÏÈËÐÔ°×ÄÚÕÏÖÎÁÆ„ˆ
Åú×¼ÈÕÆÚ£º2007Äê12ÔÂ
É̘ËÃû
CATALIN FOR OPHTHALMIC 0.005£¥
Ò»°ãÃû
¥Ô¥ì¥Î¥­¥·¥ó£¨Pirenoxine£©¡²JAN¡³
»¯Ñ§Ãû
1-Hydroxy-5-oxo-5H -pyrido£Û3, 2-α£Ýphenoxazine-3-carboxylic acid
˜‹Ôìʽ
·Ö×Óʽ
C16H8N2O5
·Ö×ÓÁ¿
308.25
ÐÔ×´
ßÁŵ¿ËÐÁÊÇרºÖÉ«·ÛÄ©£¬ÎÞ³ô£¬Î¶Î¢¿à¡£
Ëü¼«²»ÈÜÓÚ¶þ¼×»ùÑÇí¿£¬¼¸ºõ²»ÈÜÓÚË®£¬ÒÒëæ£¬ÒÒ´¼£¨95£©£¬ËÄÇâ߻ૻòÒÒÃÑ¡£
È۵㣺Լ250°C£¨·Ö½â£©
´¦Àí×¢ÒâÊÂÏî
×¢Òâ
Çë×¢Ò⣬ÓÉÓÚ½ðÊôÀë×ӵĻìÈ룬±¾²úÆ·»á¸Ä±äÉ«µ÷¡£
±£´æ
£¨1£©ÊÒα£´æ
£¨2£©Èܽâºó£¬ÔÚÒõÁ¹´¦±£´æ£¬²¢ÔÚ3ÖÜÄÚʹÓá£
ҩЧҩÀí
¸ù¾Ýà­ÅµÍªÀíÂÛ£¬¾Ý³Æ°×ÄÚÕϵÄÔ­ÒòÊǾ§×´ÌåµÄË®ÈÜÐÔµ°°×Öʱ»Óк˰±»ùËáµÄ´úлÎÉÂÒ£¨É«°±ËᣬÀÒ°±ËáµÈ£©²úÉúµÄà­ÅµÍªÎïÖʱäÐԺͲ»ÈÜ£¬¶øßÁ¿©ÍéͪÊÇà­ÅµÍªÎïÖÊ¡£¾ºÕùÐÔµØÒÖÖÆÁ˸Ã×÷ÓÃÒÔά³Ö¾§×´ÌåµÄ͸Ã÷ÐÔ£¬´Ó¶øÒÖÖÆÁ˰×ÄÚÕϵĽøÕ¹£¨ëàÊó£¬ÌåÍ⣩¡£
ÊÊÓ¦Ö¢
³õÆÚÀÏÈËÐÔ°×ÄÚÕÏ
Ó÷¨ÓëÓÃÁ¿
ʹÓÃǰ½«¿ÅÁ£ÈܽâÔÚÈÜÒºÖУ¬Ã¿ÌìµÎÈë1ÖÁ2µÎ£¬Ã¿Ìì3ÖÁ5´Î¡£
*ÓйØÈçºÎÈܽâ¿ÅÁ£µÄÏêϸÐÅÏ¢£¬Çë²Î¼û“ÆäËû˵Ã÷£¨¸½´øÉ豸µÄ´¦Àí£©”¡£
°ü×°
£¨Ò»¸öƬ¼ÁÑÛ¿ÆÈÜÒººÍÈܽâÒº15ºÁÉý£©×10
£¨Ò»¸öƬ¼ÁÑÛ¿ÆÈÜÒººÍÈܽâÒº15ºÁÉý£©×50
ÖÆÔì³§ÉÌ
ǧÊÙÒ©ÒµÓÐÏÞ¹«Ë¾
ÏúÊÛ
ÎäÌïÖÆÒ©ÓÐÏÞ¹«Ë¾
×¢£ºÒÔÉÏÖÐÎÄ´¦·½×ÊÁϲ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ­´¦·½Îª×¼£¡
ÍêÕû˵Ã÷×ÊÁϸ½¼þ£º
https://www.info.pmda.go.jp/go/pack/1319706Q2039_1_05/
CATALIN FOR OPHTHALMIC 0.005%£¨¥«¥¿¥ê¥óµãÑÛÓÃ0.005£¥£©
Brand name: CATALIN FOR OPHTHALMIC 0.005%
¡¡Active ingredient:Pirenoxine
¡¡Dosage form: orangish yellow tablet, clear and colorless solvent, after dissolution; clear and yellow ophthalmic solution,(solvent bottle)with large white cap and small brown cap
¡¡Print on wrapping:
Effects of this medicine
This medicine prevents water-soluble protein in the crystal lens from insolubilization so as to maintain transparency of the lens, and consequently suppresses progression of cataract.
It is usually used to control the progress of early senile cataract.
Before using this medicine, be sure to tell your doctor and pharmacist
•If you have previously experienced any allergic reactions(itch, rash, etc.)to any medicines.
If you wear contact lenses.
•If you are pregnant or breastfeeding.
•If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
•Your dosing schedule prescribed by your doctor is<<to be written by a healthcare professional>>
•Dissolve the tablet in the solvent just before use. In general, apply 1 to 2 drops at a time, 3 to 5 times daily. Strictly follow the instructions.
•Following the instruction attached in the box, drop the tablet in the solvent and dissolve it shaking well.
•Before using, wash your hands with soap and water. Then warm the bottle by hand for a while (when you apply the medicine right after taking from cold storage, it may drop successively caused by cold air expanding in the bottle). Remove the small brown cap only while keeping the large white cap tightly closed and apply the medicine not to touch the tip of eye dropper to any surface of your eye. After instilling, close your eyes and do not blink for a while. Wipe off any excess liquid with a clean gauze or tissue. If you need to use other eye drops at the same time, wait more than 5 minutes.
•If you miss a dose, apply a dose as soon as possible. If it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. You should not use two doses at one time.
•If you accidentally use more than your prescribed dose, consult with your doctor or pharmacist.
•Do not stop using this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
•Possible adverse reactions to this medicine
The most commonly reported adverse reactions include blepharitis (eyelid inflammation), contact dermatitis (rash in the area where the medicine is attached), diffuse superficial keratitis (foreign-body sensation, eye pain, sensitive to light, teary eye), conjunctival congestion, conjunctivitis, irritation in the eye, itching in the eye, foggy vision, eye discharge, lacrimation, eye pain, abnormal sensation in the eye and foreign-body sensation in the eye.If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets.If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
No pertinent entries.
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
•Keep out of the reach of children. Store at room temperature (1-30¡æ), away from direct sunlight.
•After dissolution, store away from light in a cold place (1-15¡æ), and use within 3 weeks.
•Discard the remainder. Do not store them.
•To avoid improper use and quality loss, do not transfer this solution to any other bottle or container.
•Do not use any other solution in this bottle.
Senju Pharmaceutical Co.,Ltd.External
Revised: 12/2013
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. 

¡¾´ó ÖРС¡¿¡¾´òÓ¡¡¿ ¡¾·±Ìå¡¿¡¾Í¶¸å¡¿¡¾Êղء¿ ¡¾ÍƼö¡¿¡¾¾Ù±¨¡¿¡¾ÆÀÂÛ¡¿ ¡¾¹Ø±Õ¡¿ ¡¾·µ»Ø¶¥²¿¡¿
·ÖÏíµ½QQ¿Õ¼ä
·ÖÏíµ½: 
ÉÏһƪ£ºCATALIN FOR OPHTHALMIC 0.005% 1.. ÏÂһƪ£ºCATALIN-K FOR OPHTHALMIC 0.005%..

Ïà¹ØÀ¸Ä¿

×îÐÂÎÄÕÂ

ͼƬÖ÷Ìâ

ÈÈÃÅÎÄÕÂ

ÍÆ¼öÎÄÕÂ